Screener
ARS Pharmaceuticals, Inc. SPRY PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026.
- Filed
- May 15, 2026, 6:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-225142
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 6,788 | 6,194 |
| Total current assets | 245,236 | 284,896 |
| Inventories, noncurrent | 23,221 | 23,053 |
| Property, plant and equipment, net | 2,285 | 2,465 |
| Intangible assets, net | 14,176 | 14,452 |
| Other assets | 2,653 | 2,786 |
| Total assets | $287,571 | $327,652 |
| Liabilities and stockholders’ equity |
Item 1. Financial Statements
FAQ
- What is ARS Pharmaceuticals, Inc.'s PP&E (net)?
- ARS Pharmaceuticals, Inc. (SPRY) reported PP&E (net) of $2.29M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s PP&E (net) changed year-over-year?
- ARS Pharmaceuticals, Inc.'s PP&E (net) increased by 112.6% year-over-year, from $1.08M to $2.29M.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), ARS Pharmaceuticals, Inc.'s PP&E (net) has grown at a 8.8% compound annual growth rate (CAGR), from $1.62M to $2.47M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about ARS Pharmaceuticals, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude